|
The hallucinogen psilocybin appears to be safe and feasible to give to patients with advanced-stage cancer and anxiety - a study published in Archives of General Psychiatry reports it had a promising effect on mood. Psilocybin is the active ingredient in an illegal Class A drug in the UK called magic mushroom...
Dr. Robert Olson, a radiation oncologist, is the first physician to be hired for the BC Cancer Agency Centre for the North. He will be part of the provincial Radiation Therapy Program which will bring service to the North for the first time when the new centre is opened. The centre, now under construction, is expected to start treating patients by the end of 2012. Dr...
CSI Laboratories®, a private national cancer diagnostic laboratory, announced the lease of a new 65,000 square foot facility in Alpharetta, GA, located north of the city of Atlanta. CSI Laboratories is committing $15 million to its strategic expansion project, and this newly leased space will house its next generation laboratory, with clinical operations beginning in mid-2011...
Celgene Corporation (NASDAQ: CELG) announced it has received a Paragraph IV Certification Letter advising that Natco Pharma Limited of Hyderabad, India, submitted an Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Administration (FDA)...
Progress in childhood cancer is a good news story. Children treated for cancer have an overall 70-80 per cent cure rate. As the numbers of survivors of childhood cancer increases, studies of the long-term survivors allow research that can guide newer treatment protocols and further improve the outlook for newly diagnosed patients...
An integrated approach to cancer care needs to be developed in Australia that incorporates psychosocial and biological interventions, according to an article published in a Medical Journal of Australia supplement. The Anxiety, Depression and Cancer supplement is the product of a partnership between beyondblue and the Cancer Council Australia...
Biologists at the University of California, San Diego have discovered that a gene critical for programmed cell death is also important in the loss of adult stem cells, a finding that could help to improve the health and well-being of patients undergoing cancer treatment...
Cancer diagnosis and treatment planning took another major step forward with the release of the Request for Proposals (RFP) for the purchase and installation of a second positron emission tomography/computed tomography (PET/CT) scanner at the BC Cancer Agency...
Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, announced the publication of a research article in Bioorganic & Medicinal Chemistry Letters on the anti-tumor activity of RX-8243 and its analogues...
The decision regarding treatment following breast-conserving surgery for patients diagnosed with ductal carcinoma in-situ (DCIS) has long been an area of discussion and confusion for patients and physicians alike. While the mortality rates for DCIS remain low, the risk of local recurrence in the breast is high. Standard treatments following surgery include radiation therapy and hormone treatment...
Recent studies have shown that acupuncture can help control a number of symptoms and side effects -- such as pain, fatigue, dry mouth, nausea, and vomiting -- associated with a variety of cancers and their treatments...
About one-third of women diagnosed with early-stage breast cancer will have their cancer travel, or metastasize, to other parts of the body, with the bone being the most common site of initial detectable spread...
Millennium: The Takeda Oncology Company announced the publication of an article in the journal Blood describing the novel mechanism of action of MLN4924 through targeted pathway modulation in diffuse large B-cell lymphoma (DLBCL). MLN4924 is a small molecule inhibitor of the NEDD8-Activating Enzyme (NAE), a key component of the protein homeostasis pathway...
Scientists have built a clearer picture of how lengthy strands of DNA are concertinaed when our cells grow and divide, in a discovery could help explain how cell renewal can go wrong. Scientists have identified thousands of proteins that play a key role in compacting DNA - a crucial process by which DNA is shortened up to 10,000 times to fit inside cells as they split into two...
A basic requirement for growth and life of a multicellular organism is the ability of its cells to divide. Chromosomes in the cells duplicate and are then distributed among the daughter cells. This distribution is organized by a protein complex made up of several hundred different proteins, called the centrosome...
In two closely related studies, two teams of Scripps Research Institute scientists have discovered the underlying mechanisms that activate a type of immune cell in the skin and other organs. The findings may lead to the development of new therapies to treat inflammation, wounds, asthma, and malignant tumors...
Stem cells might be thought of as trunks in the tree of life. All multi-cellular organisms have them, and they can turn into a dazzling variety other cells - kidney, brain, heart or skin, for example...
Researchers have made a major breakthrough in finding out how aggressive cancers originate, raising hope of novel targeted therapies for future breast cancer patients, according to a study published in the peer-reviewed journal Cell Stem Cell...
Macmillan Cancer Support and Boots UK today officially launched a groundbreaking new three-year partnership, which aims to help provide the two million people living with cancer, and their family and friends, increased access to the information and support they need - when they need it, where they need it...
Celsion Corporation (Nasdaq: CLSN), a biotechnology drug development company, announced that it has been awarded a competitive Phase I Small Business Innovation and Research (SBIR) grant from the National Institutes of Health (NIH), to support the proposal, "New Thermal Sensitive Carboplatin Liposomes for Cancer"...
Treatments modelled on the cancer drug Gleevec could potentially prevent the formation of amyloid plaques - one of the major hallmarks of Alzheimer's disease according to a study. Treatments modelled on the cancer drug Gleevec could potentially prevent the formation of amyloid plaques - one of the major hallmarks of Alzheimer's disease according to a study published in the journal Nature...
Twenty-first-century pharmaceutical breakthroughs require 21st-century drug discovery tools, such as computational or in silico molecular design and high-throughput screening of effective, new compounds. That's the theme of a University at Buffalo symposium to be held Sept...
Today, at the Engineering in Medicine and Biology Conference (EMBC) in Buenos Aires (Argentina), imec and its project partners have announced the launch of the European Seventh Framework Project MIRACLE. The MIRACLE project aims to develop an operational lab-on-chip for the isolation and detection of circulating and disseminated tumor cells (CTCs and DTCs) in blood...
A "game-changing" technique using near infrared light enables scientists to look deeper into the guts of cells, potentially opening up a new frontier in the fights against cancer and many other diseases. University of Central Florida chemists, led by Professor Kevin Belfield, used near infrared light and fluorescent dye to take pictures of cells and tumors deep within tissue...
A new study from the Center for Interdisciplinary Chronobiological Research at the University of Haifa has found an additional link between Light At Night (LAN) and cancer. This research joins a series of earlier studies carried out at the University of Haifa that also established the correlation...
|